Daclatasvir Dihydrochloride-impurities | Pharmaffiliates

daclatasvir dihydrochloride

Daclatasvir is a direct-acting antiviral agent against Hepatitis C Virus used for the treatment of chronic HCV genotype 1 and 3 infection. It is sold under the trade name Daklinza.. Reference standards of Daclatasvir Dihydrochloride API, and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below

stdClass Object
(
    [pname] => Daclatasvir Dihydrochloride - API Standards 
    [catalogue_number] => PA 31 39000
    [category_ids] => ,80,77,78,70,82,
    [chemical_name] => 
    [weight] => 811.80
    [form] => C40H52Cl2N8O6
    [cas] => 1009119-65-6
    [pslug] => 1009119-65-6-daclatasvir-dihydrochloride-api-pa3139000
    [latest_product] => 0
    [linkproducts] => 1
    [offers_id] => 8
    [offers_name] => Ready Stock
    [offers_status] => 1
    [offers_start_date] => 2024-12-16
    [offers_end_date] => 2024-12-31
    [pageview] => 2
    [offers_slug] => ready-stock
    [offers_product_id] => 48093
    [offers_product_code] => PA 31 39000
    [offers_master_id] => 8
    [offer_percentage] => 20 % OFF
    [offers_product_main_cat] => Pharmaceutical Reference Standards
)
PA 31 39000

Daclatasvir Dihydrochloride - API Standards


  • Catalogue No.:PA 31 39000

  • CAS :

    1009119-65-6

  • Molecular Formula : C40H52Cl2N8O6

  • Molecular Weight : 811.80